T.R. Winston’s Healthcare banking team assists in the development of financing and growth strategies for both private and public companies. Our clients cover a broad spectrum of sectors, including companies engaged in the clinical development of new therapeutic compounds, drug discovery techniques, medical technologies, and devices. We work with companies that require cash to complete the development of their product portfolio, as well as companies that need capital to fund the commercial launch of their programs. We also work closely with management and the Board of Directors in evaluating acquisition opportunities, licenses and strategic partnerships to accelerate growth and enhance shareholder value.    

PRODUCTS AND SERVICES INCLUDE:

  • Public and private offerings of equity and debt
  • FDA regulation and policy advisory
  • Product development analysis
  • Commercial distribution assessment
  • Clinical trial and process support

 

SUB-SECTOR FOCUS INCLUDES:

  • Biotechnology
  • Drug development
  • Specialty pharmaceuticals
  • Medical technologies
  • Healthcare services and IT

RECENT TRANSACTIONS

20180214February 2018 Capital Markets $143,750,000 Healthcare
20170925September 2017 Strategic Advisory Undisclosed Healthcare
20161025October 2016 Capital Markets NA Healthcare